332 related articles for article (PubMed ID: 19940355)
21. Pro-inflammatory cytokines TNF-related weak inducer of apoptosis (TWEAK) and TNFalpha induce the mitogen-activated protein kinase (MAPK)-dependent expression of sclerostin in human osteoblasts.
Vincent C; Findlay DM; Welldon KJ; Wijenayaka AR; Zheng TS; Haynes DR; Fazzalari NL; Evdokiou A; Atkins GJ
J Bone Miner Res; 2009 Aug; 24(8):1434-49. PubMed ID: 19292615
[TBL] [Abstract][Full Text] [Related]
22. Pulsating fluid flow modulates gene expression of proteins involved in Wnt signaling pathways in osteocytes.
Santos A; Bakker AD; Zandieh-Doulabi B; Semeins CM; Klein-Nulend J
J Orthop Res; 2009 Oct; 27(10):1280-7. PubMed ID: 19353691
[TBL] [Abstract][Full Text] [Related]
23. Osteocyte control of bone formation via sclerostin, a novel BMP antagonist.
Winkler DG; Sutherland MK; Geoghegan JC; Yu C; Hayes T; Skonier JE; Shpektor D; Jonas M; Kovacevich BR; Staehling-Hampton K; Appleby M; Brunkow ME; Latham JA
EMBO J; 2003 Dec; 22(23):6267-76. PubMed ID: 14633986
[TBL] [Abstract][Full Text] [Related]
24. Estrogen Modulates Bone Morphogenetic Protein-Induced Sclerostin Expression Through the Wnt Signaling Pathway.
Kim RY; Yang HJ; Song YM; Kim IS; Hwang SJ
Tissue Eng Part A; 2015 Jul; 21(13-14):2076-88. PubMed ID: 25837159
[TBL] [Abstract][Full Text] [Related]
25. Osteocytic cells exposed to titanium particles increase sclerostin expression and inhibit osteoblastic cell differentiation mostly via direct cell-to-cell contact.
Chai H; Zhang ZH; Fang JY; She C; Geng C; Xu W
J Cell Mol Med; 2022 Aug; 26(15):4371-4385. PubMed ID: 35762300
[TBL] [Abstract][Full Text] [Related]
26. Hypoxia decreases sclerostin expression and increases Wnt signaling in osteoblasts.
Genetos DC; Toupadakis CA; Raheja LF; Wong A; Papanicolaou SE; Fyhrie DP; Loots GG; Yellowley CE
J Cell Biochem; 2010 May; 110(2):457-67. PubMed ID: 20336693
[TBL] [Abstract][Full Text] [Related]
27. Osteocyte-derived sclerostin inhibits bone formation: its role in bone morphogenetic protein and Wnt signaling.
ten Dijke P; Krause C; de Gorter DJ; Löwik CW; van Bezooijen RL
J Bone Joint Surg Am; 2008 Feb; 90 Suppl 1():31-5. PubMed ID: 18292354
[TBL] [Abstract][Full Text] [Related]
28. Rat Osteosarcoma Cells as a Therapeutic Target Model for Osteoregeneration via Sclerostin Knockdown.
Sedaghati B; Jahroomishirazi R; Starke A; Hacker MC; Schulz-Siegmund M
Cells Tissues Organs; 2016; 201(5):366-79. PubMed ID: 27233518
[TBL] [Abstract][Full Text] [Related]
29. Distinct modes of inhibition by sclerostin on bone morphogenetic protein and Wnt signaling pathways.
Krause C; Korchynskyi O; de Rooij K; Weidauer SE; de Gorter DJ; van Bezooijen RL; Hatsell S; Economides AN; Mueller TD; Löwik CW; ten Dijke P
J Biol Chem; 2010 Dec; 285(53):41614-26. PubMed ID: 20952383
[TBL] [Abstract][Full Text] [Related]
30. Targeted disruption of BMP signaling through type IA receptor (BMPR1A) in osteocyte suppresses SOST and RANKL, leading to dramatic increase in bone mass, bone mineral density and mechanical strength.
Kamiya N; Shuxian L; Yamaguchi R; Phipps M; Aruwajoye O; Adapala NS; Yuan H; Kim HK; Feng JQ
Bone; 2016 Oct; 91():53-63. PubMed ID: 27402532
[TBL] [Abstract][Full Text] [Related]
31. Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist.
van Bezooijen RL; Roelen BA; Visser A; van der Wee-Pals L; de Wilt E; Karperien M; Hamersma H; Papapoulos SE; ten Dijke P; Löwik CW
J Exp Med; 2004 Mar; 199(6):805-14. PubMed ID: 15024046
[TBL] [Abstract][Full Text] [Related]
32. BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop.
Rawadi G; Vayssière B; Dunn F; Baron R; Roman-Roman S
J Bone Miner Res; 2003 Oct; 18(10):1842-53. PubMed ID: 14584895
[TBL] [Abstract][Full Text] [Related]
33. Recombinant sclerostin antagonizes effects of ex vivo mechanical loading in trabecular bone and increases osteocyte lacunar size.
Kogawa M; Khalid KA; Wijenayaka AR; Ormsby RT; Evdokiou A; Anderson PH; Findlay DM; Atkins GJ
Am J Physiol Cell Physiol; 2018 Jan; 314(1):C53-C61. PubMed ID: 28978523
[TBL] [Abstract][Full Text] [Related]
34. Osteocyte control of bone remodeling: is sclerostin a key molecular coordinator of the balanced bone resorption-formation cycles?
Sapir-Koren R; Livshits G
Osteoporos Int; 2014 Dec; 25(12):2685-700. PubMed ID: 25030653
[TBL] [Abstract][Full Text] [Related]
35. Bone overgrowth-associated mutations in the LRP4 gene impair sclerostin facilitator function.
Leupin O; Piters E; Halleux C; Hu S; Kramer I; Morvan F; Bouwmeester T; Schirle M; Bueno-Lozano M; Fuentes FJ; Itin PH; Boudin E; de Freitas F; Jennes K; Brannetti B; Charara N; Ebersbach H; Geisse S; Lu CX; Bauer A; Van Hul W; Kneissel M
J Biol Chem; 2011 Jun; 286(22):19489-500. PubMed ID: 21471202
[TBL] [Abstract][Full Text] [Related]
36. Sclerostin neutralization unleashes the osteoanabolic effects of Dkk1 inhibition.
Witcher PC; Miner SE; Horan DJ; Bullock WA; Lim KE; Kang KS; Adaniya AL; Ross RD; Loots GG; Robling AG
JCI Insight; 2018 Jun; 3(11):. PubMed ID: 29875318
[TBL] [Abstract][Full Text] [Related]
37. An Akt-dependent increase in canonical Wnt signaling and a decrease in sclerostin protein levels are involved in strontium ranelate-induced osteogenic effects in human osteoblasts.
Rybchyn MS; Slater M; Conigrave AD; Mason RS
J Biol Chem; 2011 Jul; 286(27):23771-9. PubMed ID: 21566129
[TBL] [Abstract][Full Text] [Related]
38. Sclerostin mediates bone response to mechanical unloading through antagonizing Wnt/beta-catenin signaling.
Lin C; Jiang X; Dai Z; Guo X; Weng T; Wang J; Li Y; Feng G; Gao X; He L
J Bone Miner Res; 2009 Oct; 24(10):1651-61. PubMed ID: 19419300
[TBL] [Abstract][Full Text] [Related]
39. PTHrP-Derived Peptides Restore Bone Mass and Strength in Diabetic Mice: Additive Effect of Mechanical Loading.
Maycas M; McAndrews KA; Sato AY; Pellegrini GG; Brown DM; Allen MR; Plotkin LI; Gortazar AR; Esbrit P; Bellido T
J Bone Miner Res; 2017 Mar; 32(3):486-497. PubMed ID: 27683064
[TBL] [Abstract][Full Text] [Related]
40. Pigment epithelium derived factor regulates human Sost/Sclerostin and other osteocyte gene expression via the receptor and induction of Erk/GSK-3beta/beta-catenin signaling.
Li F; Cain JD; Tombran-Tink J; Niyibizi C
Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3449-3458. PubMed ID: 30076958
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]